PBC | Breast cancer | |
Gender | F:M 9:1 (2) | F:M 99:1 (40) |
Age | Most common in fifth and sixth decade2 | 50% over 6515 |
Prognosis | 70% response rate6 | >70% 5-year survival15 |
Long-term treatment required | Yes, UDCA | Some cases—hormonal treatment |
Long-term symptoms | Itch and fatigue | Lymphoedema |
PBC, primary biliary cholangitis; UDCA, ursodeoxycholic acid.